---
title: "Corbus Pharmaceuticals Holdings, Inc. (CRBP.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRBP.US.md"
symbol: "CRBP.US"
name: "Corbus Pharmaceuticals Holdings, Inc."
industry: "Biotechnology"
datetime: "2026-05-20T06:09:27.274Z"
locales:
  - [en](https://longbridge.com/en/quote/CRBP.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRBP.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRBP.US.md)
---

# Corbus Pharmaceuticals Holdings, Inc. (CRBP.US)

## Company Overview

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.corbuspharma.com](https://www.corbuspharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.92 | 245 | - | - | - |
| PB | 1.28 | 123 | 1.60 | 1.26 | 0.90 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **10**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 9 | 90% |
| Overweight | 1 | 10% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 9.15 |
| Highest Target | 57.00 |
| Lowest Target | 28.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CRBP.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CRBP.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CRBP.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CRBP.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**